Pacira BioSciences, Inc. PCRX Business Segments — Net Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s business segments — net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s business segments — net income?
- Pacira BioSciences, Inc. (PCRX) reported business segments — net income of $2.92M in Q1 2026.
- How has Pacira BioSciences, Inc.'s business segments — net income changed year-over-year?
- Pacira BioSciences, Inc.'s business segments — net income decreased by 39.4% year-over-year, from $4.81M to $2.92M.
- What does business segments — net income mean?
- This metric represents the final bottom-line profitability of the reportable segment after all expenses, including taxes, have been deducted. It is the definitive measure of the segment's contribution to the overall company's net earnings. A positive trend indicates sustainable growth and effective management of both costs and revenues.